Merck to Acquire Caraway Therapeutics, Inc.
22 Nov 2023 //
BUSINESSWIRE
Caraway Therapeutics to Present at 22nd Annual Needham Healthcare Conference
12 Apr 2023 //
BUSINESSWIRE
Caraway Therapeutics to Present at Stifel CNS Days
22 Mar 2023 //
BUSINESSWIRE
Caraway to Present at the 33rd Annual Oppenheimer Healthcare Conference
08 Mar 2023 //
BUSINESSWIRE
Caraway & Ash Partner to Address Surge in Gen Z Sexually Transmitted Infections
14 Feb 2023 //
PR NEWSWIRE
Caraway Therapeutics to Present at Two Upcoming Investor Conferences
07 Oct 2022 //
BUSINESSWIRE
Caraway to Present at Michael J. Fox Foundation’s Parkinson’s Disease Conference
06 Oct 2022 //
BUSINESSWIRE
Caraway Therapeutics to Participate in William Blair Biotech Focus Conference
06 Jul 2022 //
BUSINESSWIRE
Caraway Therapeutics to Participate at Two Upcoming Investor Events
22 Mar 2022 //
BUSINESSWIRE
Caraway Therapeutics to Present at Oppenheimer 32nd Annual Healthcare Conference
08 Mar 2022 //
BUSINESSWIRE
Caraway Therapeutics Expands Scientific Advisory Board; Appoints David Clapham
02 Mar 2022 //
BUSINESSWIRE
Caraway Therapeutics Receives Third Research Grant for TRPML1 Agonists
26 Jan 2022 //
BUSINESSWIRE